Growing community of inventors

Espoo, Finland

Petteri Rummakko

Average Co-Inventor Count = 4.05

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 10

Petteri RummakkoArne Grumann (6 patents)Petteri RummakkoDavid Din Belle (8 patents)Petteri RummakkoPekka Pietikäinen (6 patents)Petteri RummakkoSoini Huhta (4 patents)Petteri RummakkoLeif Hilden (3 patents)Petteri RummakkoTuomas Huuhtanen (2 patents)Petteri RummakkoPekka Pietikaeinen (2 patents)Petteri RummakkoViesturs Lusis (1 patent)Petteri RummakkoMarko Ahlmark (2 patents)Petteri RummakkoTuomas Koiranen (1 patent)Petteri RummakkoGerd Wohlfahrt (0 patent)Petteri RummakkoJulius Sipilä (0 patent)Petteri RummakkoDimitris Noutsias (0 patent)Petteri RummakkoPetteri Rummakko (6 patents)Arne GrumannArne Grumann (8 patents)David Din BelleDavid Din Belle (8 patents)Pekka PietikäinenPekka Pietikäinen (6 patents)Soini HuhtaSoini Huhta (4 patents)Leif HildenLeif Hilden (4 patents)Tuomas HuuhtanenTuomas Huuhtanen (2 patents)Pekka PietikaeinenPekka Pietikaeinen (2 patents)Viesturs LusisViesturs Lusis (3 patents)Marko AhlmarkMarko Ahlmark (2 patents)Tuomas KoiranenTuomas Koiranen (1 patent)Gerd WohlfahrtGerd Wohlfahrt (0 patent)Julius SipiläJulius Sipilä (0 patent)Dimitris NoutsiasDimitris Noutsias (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Fermion Oy (4 from 12 patents)

2. Orion Corporation, Fermion (2 from 4 patents)

3. Orion Corporation (178 patents)


6 patents:

1. 8044038 - Crystallization process of quetiapine hemifumarate

2. 8044039 - Quetiapine hemifumarate purification by crystallization

3. 7863441 - Preparation of quetiapine

4. 7858777 - Preparation method for quetiapine

5. 6753433 - Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile

6. 6579993 - Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/17/2025
Loading…